The results revealed that CD5L, DUSP8, CD24, and SLC16A1 were significantly different between MASH and control samples and demonstrated strong predictive power for MASH occurrence (Supplementary Figure S1). The gene discussed is CD5L; the disease is metabolic dysfunction-associated steatohepatitis.